FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2339331332> ?p ?o ?g. }

• W2339331332 endingPage "1052" @default.
• W2339331332 startingPage "1043" @default.
• W2339331332 abstract "We performed a retrospective analysis on 45 patients who, between January 1989 and October 1993, received VAPEC-B chemotherapy for high and intermediate grade non-Hodgkin's lymphoma. The aim was to assess response and tolerance to treatment. The weekly regimen consisted of: doxorubicin 35 mg/m2 i.v. weeks 1,3,5,7,9,11; cyclophosphamide 350 mg/m2 i.v. weeks 1, 5, 9; etoposide 100 mg/m2 p.o. daily for 5 days, weeks 3,7,11; vincristine 1.4 mg/m2 i.v. (2 mg max.) weeks 2, 4, 6, 8, 10; bleomycin 10 mg/m2 i.v. weeks 2, 6, 10; methotrexate 12.5 mg i.t. weeks 1, 5, 9; prednisolone 50 mg p.o. daily for 6 weeks, reduced to 25 mg daily for 6 weeks. The patients treated were aged 22–71 years, 34 (75%) had high grade (Working Formulation) non-Hodgkin's lymphoma (NHL); 11 (24%) had intermediate grade NHL; 25 had Stage III/IV disease; and 14 (31%) had marrow involvement. The majority of patients (76%) received VAPEC-B as first line chemotherapy; the remainder received it for relapsing disease. Follow-up time from completion of VAPEC-B chemotherapy ranged from 6 months to 50 months (median 25). VAPEC-B, as first line therapy, induced a complete response (CR) and partial response (PR) in 79% and 18% respectively, whilst 3% had no response to treatment. VAPEC-B used for relapsing disease produced CR and PR in 64% and 27% respectively, whilst 9% failed to respond. Six patients in PR and five patients in CR have subsequently undergone an autologous bone marrow transplant or a peripheral blood stem cell transplant. In the group who received VAPEC-B first line but did not proceed to transplant (27 patients), five relapsed (three with CNS disease who had not had CNS prophylaxis). Tolerance to treatment was measured by WHO toxicity scores. The haemoglobin (Hb) toxicity median score for all patients was grade 1 (Hb 9.5–10.9 g/dl), and the white cell count (WCC), toxicity score was grade 2 (WCC 2.0–2.9 × 109/l). No platelet toxicity was observed. Ten per cent of patients suffered grade 3 severity infections requiring antibiotics and there was one treatment related death. The majority of patients received VAPEC-B on time, however, 24% patients had a 2-week delay.VAPEC-B chemotherapy is an effective regimen for malignant lymphoma, either as a first line or as a salvage treatment. Although chemotherapy was given weekly, the tolerance to treatment was acceptable, thus making this short regimen a good alternative to CHOP chemotherapy." @default.
• W2339331332 created "2016-06-24" @default.
• W2339331332 creator A5035601705 @default.
• W2339331332 creator A5040941721 @default.
• W2339331332 creator A5082720713 @default.
• W2339331332 date "1976-09-01" @default.
• W2339331332 modified "2023-10-16" @default.
• W2339331332 title "Chemotherapy of the Non-Hodgkin's Lymphomas" @default.
• W2339331332 cites W2016932842 @default.
• W2339331332 cites W2020893327 @default.
• W2339331332 cites W2034359426 @default.
• W2339331332 cites W2036089223 @default.
• W2339331332 cites W2080319707 @default.
• W2339331332 cites W2087307665 @default.
• W2339331332 cites W2088920936 @default.
• W2339331332 cites W2097795171 @default.
• W2339331332 cites W2337564024 @default.
• W2339331332 cites W4243547639 @default.
• W2339331332 cites W4292705219 @default.
• W2339331332 cites W4300709251 @default.
• W2339331332 doi "https://doi.org/10.1016/s0025-7125(16)31847-8" @default.
• W2339331332 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/59842" @default.
• W2339331332 hasPublicationYear "1976" @default.
• W2339331332 type Work @default.
• W2339331332 sameAs 2339331332 @default.
• W2339331332 citedByCount "7" @default.
• W2339331332 countsByYear W23393313322022 @default.
• W2339331332 countsByYear W23393313322023 @default.
• W2339331332 crossrefType "journal-article" @default.
• W2339331332 hasAuthorship W2339331332A5035601705 @default.
• W2339331332 hasAuthorship W2339331332A5040941721 @default.
• W2339331332 hasAuthorship W2339331332A5082720713 @default.
• W2339331332 hasConcept C126322002 @default.
• W2339331332 hasConcept C141071460 @default.
• W2339331332 hasConcept C2776232574 @default.
• W2339331332 hasConcept C2776694085 @default.
• W2339331332 hasConcept C2776715498 @default.
• W2339331332 hasConcept C2776755627 @default.
• W2339331332 hasConcept C2778119113 @default.
• W2339331332 hasConcept C2778336483 @default.
• W2339331332 hasConcept C2778476748 @default.
• W2339331332 hasConcept C2779338263 @default.
• W2339331332 hasConcept C2779429289 @default.
• W2339331332 hasConcept C2780039790 @default.
• W2339331332 hasConcept C2781059491 @default.
• W2339331332 hasConcept C2781413609 @default.
• W2339331332 hasConcept C71924100 @default.
• W2339331332 hasConcept C90924648 @default.
• W2339331332 hasConceptScore W2339331332C126322002 @default.
• W2339331332 hasConceptScore W2339331332C141071460 @default.
• W2339331332 hasConceptScore W2339331332C2776232574 @default.
• W2339331332 hasConceptScore W2339331332C2776694085 @default.
• W2339331332 hasConceptScore W2339331332C2776715498 @default.
• W2339331332 hasConceptScore W2339331332C2776755627 @default.
• W2339331332 hasConceptScore W2339331332C2778119113 @default.
• W2339331332 hasConceptScore W2339331332C2778336483 @default.
• W2339331332 hasConceptScore W2339331332C2778476748 @default.
• W2339331332 hasConceptScore W2339331332C2779338263 @default.
• W2339331332 hasConceptScore W2339331332C2779429289 @default.
• W2339331332 hasConceptScore W2339331332C2780039790 @default.
• W2339331332 hasConceptScore W2339331332C2781059491 @default.
• W2339331332 hasConceptScore W2339331332C2781413609 @default.
• W2339331332 hasConceptScore W2339331332C71924100 @default.
• W2339331332 hasConceptScore W2339331332C90924648 @default.
• W2339331332 hasIssue "5" @default.
• W2339331332 hasLocation W23393313321 @default.
• W2339331332 hasLocation W23393313322 @default.
• W2339331332 hasOpenAccess W2339331332 @default.
• W2339331332 hasPrimaryLocation W23393313321 @default.
• W2339331332 hasRelatedWork W2051017580 @default.
• W2339331332 hasRelatedWork W2084273022 @default.
• W2339331332 hasRelatedWork W2089559525 @default.
• W2339331332 hasRelatedWork W2091953646 @default.
• W2339331332 hasRelatedWork W2093194444 @default.
• W2339331332 hasRelatedWork W2116228419 @default.
• W2339331332 hasRelatedWork W2281431331 @default.
• W2339331332 hasRelatedWork W2410697267 @default.
• W2339331332 hasRelatedWork W2412553244 @default.
• W2339331332 hasRelatedWork W2414283574 @default.
• W2339331332 hasVolume "60" @default.
• W2339331332 isParatext "false" @default.
• W2339331332 isRetracted "false" @default.
• W2339331332 magId "2339331332" @default.
• W2339331332 workType "article" @default.